Frontlight ResearchEarly access
Trial site
Institute for Pulmonary Diseases of Vojvodina
- 6running trials
- 7closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Lung cancer9 trials
- Asthma1 trial
- COPD1 trial
- Diffuse large B-cell lymphoma1 trial
- Idiopathic pulmonary fibrosis1 trial
- Phase
- Phase 39 trials
- Phase 22 trials
- Phase 2/32 trials
- Status
- Completed7 trials
- Active, not recruiting5 trials
- Recruiting1 trial
- Lead sponsor
- Hoffmann-La Roche3 trials
- Amgen2 trials
- Connect Biopharm LLC2 trials
- Incyte Corporation2 trials
- Boehringer Ingelheim1 trial
- and 3 more
Running trials
Active, not recruiting
Active, not recruiting
Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer1 recruiting
Closed trials
Completed
Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD)
Completed
Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026